STAAR Surgical Company reported $340M of revenue over the trailing twelve months, +51% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $340M (to Q2 2026). Net income: $3.8M, trailing twelve months to Q2 2026. Free cash flow: −$6.7M, trailing twelve months to Q2 2026. Operating margin: −0.17%, trailing twelve months to Q2 2026.

STAASTAAR Surgical Company

Healthcare

$21.68-20% 1Y

$21.68

$16.1052 weeks$33.34

STAA as reported

STAAR Surgical Company reported $340M of revenue over the trailing twelve months, +51% on the year before. 11 reported series are charted on this page, each one as filed.

$340M

Revenue, trailing twelve months · to Q2 2026 · +51% against the twelve months before

Net income: $3.8M
Net income · −104% year on year · trailing twelve months to Q2 2026
Free cash flow: −$6.7M
Free cash flow · −85% year on year · trailing twelve months to Q2 2026
Operating margin: −0.17%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for STAA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$340M	+51%	Q2 2026
Net income	$3.8M	−104%	Q2 2026
EPS	$0.08	−104%	Q2 2026
Gross margin	77%	n/a	Q2 2026
Operating margin	−0.17%	n/a	Q2 2026
Net margin	−2.0%	n/a	Q2 2026
ROE	−14%	n/a	Q2 2026
ROA	−11%	n/a	Q2 2026
ROIC	28%	n/a	Q3 2021 · 19 quarters behind
Free cash flow	−$6.7M	−85%	Q2 2026
P/E	271	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.